Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Immobile, Impaired work ability, Joint swelling, Peripheral swelling
Clinical narrative: It immobilized; Swelling in hips and shoulder; swelling in his fingers, that then moved up to his shoulder, and then to the hip on the opposite; Had difficulty to work; Redness in fingers; This spontaneous case was reported by a nurse and describes the occurrence of IMMOBILE (It immobilized), JOINT SWELLING (Swelling in hips and shoulder), PERIPHERAL SWELLING (swelling in his fingers, that then moved up to his shoulder, and then to the hip on the opposite), IMPAIRED WORK ABILITY (Had difficulty to work) and ERYTHEMA (Redness in fingers) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026H21A and 012L20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma (IgE Asthma).   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In March 2021, the patient experienced IMMOBILE (It immobilized), JOINT SWELLING (Swelling in hips and shoulder), PERIPHERAL SWELLING (swelling in his fingers, that then moved up to his shoulder, and then to the hip on the opposite), IMPAIRED WORK ABILITY (Had difficulty to work) and ERYTHEMA (Redness in fingers). In April 2021, IMMOBILE (It immobilized), JOINT SWELLING (Swelling in hips and shoulder), PERIPHERAL SWELLING (swelling in his fingers, that then moved up to his shoulder, and then to the hip on the opposite), IMPAIRED WORK ABILITY (Had difficulty to work) and ERYTHEMA (Redness in fingers) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported.  No treatment information was provided by the reporter.  Patient went to see a doctor and learnt about reactive arthritis after covid vaccination.  Company comment- This case concerns a 55 year old male with relevant medical history of asthma, who experienced non-serious , unexpected events of immobile, joint swelling , peripheral swelling impaired working ability and erythema which occurred 2 weeks after vaccination with the 2nd dose of Moderna Covid 19 vaccine. The re-challenge for this case is not applicable. The benefit-risk relationship of Moderna Covid 19 Vaccine is not affected by this report. Per medical reviewer's assessment and the supporting data in the SD the event immobile was downgraded to non-serious.; Sender's Comments: This case concerns a 55 year old male with relevant medical history of asthma, who experienced non-serious , unexpected events of immobile, joint swelling , peripheral swelling impaired working ability and erythema which occurred 2 weeks after vaccination with the 2nd dose of Moderna Covid 19 vaccine. The re-challenge for this case is not applicable. The benefit-risk relationship of Moderna Covid 19 Vaccine is not affected by this report. Per medical reviewer's assessment and the supporting data in the SD the event immobile was downgraded to non-serious.